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Background: Up to 60% of syncopal episodes remain unexplained. We report the results of a standard-
ized, stepwise evaluation of patients referred to an ambulatory clinic for unexplained syncope.
Methods and Results: We studied 939 consecutive patients referred for unexplained syncope, who
underwent a standardized evaluation, including history, physical examination, electrocardiogram, head-
up tilt testing (HUTT), carotid sinus massage (CSM) and hyperventilation testing (HYV). Echocardiogram
and stress test were performedwhen underlying heart disease was initially suspected. Electrophysiological
study (EPS) and implantable loop recorder (ILR) were used only in patients with underlying structural heart
disease or major unexplained syncope. We identified a cause of syncope in 66% of patients, including
27% vasovagal, 14% psychogenic, 6% arrhythmias, and 6% hypotension. Noninvasive testing identified
92% and invasive testing an additional 8% of the causes. HUTT yielded 38%, CSM 28%, HYV 49%,
EPS 22%, and ILR 56% of diagnoses. On average, patients with arrhythmic causes were older, had a
lower functional capacity, longer P-wave duration, and presented with fewer prodromes than patients
with vasovagal or psychogenic syncope.
Conclusions: A standardized stepwise evaluation emphasizing noninvasive tests yielded 2/3 of causes
in patients referred to an ambulatory clinic for unexplained syncope. Neurally mediated and psychogenic
mechanisms were behind >50% of episodes, while cardiac arrhythmias were uncommon. Sudden syn-
cope, particularly in older patients with functional limitations or a prolonged P-wave, suggests an ar-
rhythmic cause. (PACE 2009; 32:S202–S206)
unexplained syncope, standardized stepwise evaluation, diagnostic testing, psychogenic
pseudo-syncope, P-wave duration
Introduction
Syncope is a common disorder, which re-
mains unexplained in up to 60% of patients
referred to an emergency department.1,2 The in-
vestigation of unexplained syncope remains chal-
lenging. Some investigators have recently shown
the superior performance of simple investigations
in patients with syncope evaluated in emergency
departments.1–3 However, little is known of the
diagnostic performance of dedicated functional
tests. We have shown, in a recent study of the first
317 patients referred to our ambulatory syncope
clinic, that the investigation of unexplained syn-
cope, using a standardized stepwise patient evalu-
ation, yielded a diagnosis in 81% of patients, and
that compared with patients whose syncope was
neurally mediated (reflex). Those whose cause of
syncope was an arrhythmia were older, had fewer
prodromes, and had a longer P-wave duration.4
This study, which includes the first 900 ambula-
tory patients referred to our syncope clinic, (1) ex-
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amined the diagnostic performance of a standard-
ized stepwise investigation of unexplained syn-
cope, and (2) compared the clinical characteristics
of patients with arrhythmic versus reflex causes of
syncope.
Patient Population and Methods
This prospective single center study was
conducted in the ambulatory syncope clinic of
Lausanne University Hospital, in Switzerland. Pa-
tients were referred for investigation of unex-
plained syncope or presyncope. The former was
defined as a transient and self-limited loss of con-
sciousnesswith inability tomaintain postural tone
and the latter as a near syncopal event.5 Patients
with disease manifestations consistent with other
disorders, such as seizure, vertigo, or coma, were
excluded. The final population comprised 939
consecutive ambulatory patients referred to our
syncope clinic for evaluation and management of
unexplained syncope betweenDecember 1999 and
October 2007.
Figure 1 illustrates our standardized stepwise
patient evaluation. They underwent a baseline
head-up tilt test (HUTT), followed by carotid si-
nusmassage (CSM) in the supine and upright posi-
tions, and HUTT with intravenous adenosine and
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Figure 1. Standardized stepwise patient evaluation.
sublingual nitrates challenges. A hyperventilation
test (HYV)was performed only in patients present-
ing with phobic, anxious, or depressive manifes-
tations. Structural heart disease was ruled out on
the basis of patient’s history, physical examina-
tion and 12-lead electrocardiogram (ECG). Exer-
cise testing and echocardiogram were performed
when an underlying cardiac disorder was sus-
pected. An electrophysiological study (EPS) was
performed in patients presenting with an under-
lying cardiac disease or in patients whose ini-
tial noninvasive evaluation was negative, andwho
required further investigations. An implantable
loop recorder (ILR; Reveal Medtronic Inc., Min-
neapolis, MN, USA) was proposed to patients
who had undergone a negative evaluation and suf-
fered syncope-related complications. Importantly,
a positive test was classified as diagnostic when
the test-induced symptoms reproduced the clini-
cal presentation; otherwise, the test was consid-
ered abnormal, though nondiagnostic.
The initial interview focused systematically
on the presence and duration of prodromes and
recovery manifestations, including nausea, di-
aphoresis, blurred vision, paresthesia, vertigo, pal-
pitation, anxiety, tongue biting, and confusion.
Syncope-related trauma was classified as major,
when associated with a bone fracture, head or in-
ternal organ injury, or a car accident; otherwise,
it was classified as minor. The P-wave duration
was measured before any investigation to avoid a
methodological bias, by averaging three consecu-
tive cycles from leads II and AVL.
The causes of syncope were classified accord-
ing to the guidelines of the European Society of
Cardiology.5 The ultimate cause of syncope was
assigned by one of the investigators (E.P.) at the
end of the stepwise evaluation. For statistical anal-
yses, the ultimate cause of syncope was classified
as (1) arrhythmic, including bradyarrhythmias due
to atrioventricular block or sick sinus syndrome,
supra- or ventricular tachyarrhythmias, and car-
dioinhibitory carotid sinus syndrome (CSS);
(2) Vasovagal or psychogenic, including tilt-
induced syncope and psychogenic pseudo-
syncope; (3) Hypotensive, including orthostatic
hypotension and vasodepressive CSS; (4) Miscel-
laneous, including situational syncope and neuro-
logical disorders; and (5) unexplained, when none
of the above was applicable.
Statistical Analysis
Continuous variables were compared using
Student’s t-test. Categorical variables were com-
pared using the χ2 test. A P value <0.01 was con-
sidered statistically significant.
Results
Clinical Characteristics and Causes of Syncope
During the study period, 939 consecutive out-
patients were enrolled. Table I shows the baseline
clinical characteristics of the study population.
Their mean age was 52 years, and mean number of
syncopal episodeswas 10, with 13%of patients re-
ferred for presyncope only. Syncope was the cause
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Table I.
Baseline Characteristics of the Study Population
Age (y) 52 ± 21
Women 461 (49)
Hypertension 261 (28)
Hypercholesterolemia 257 (27)
Diabetes mellitus 71 (8)
Active smoker 216 (23)
Ischemic heart disease 77 (8)
Syncope frequency 10 ± 35
Presyncope only 120 (13)
Years elapsed since first episode 5 ± 8
Minor trauma 251 (27)
Major trauma 105 (11)
Hospitalization 497 (53)
Car accident 60 (6)
Driving license withdrawal 33 (3.5)
Values are means ± standard deviation or numbers (%) of
observations.
of hospitalization in 53%, car accident in 6%, and
driving licensewithdrawal in 3.5% of the patients.
Table II shows the final causes of syncope, diag-
nosed after the standardized stepwise evaluation.
Overall, a final diagnosis was established in 66%,
while syncope remained unexplained in 34%.
Importantly, arrhythmic causes were uncommon
(6%), while neurally mediated syncope was diag-
nosed in 42%, including tilt-induced syncope in
Table II.
Final Causes of Syncope
n (%)
Neurally mediated 396 (42)
Vasovagal (tilt-induced) 258 (27)
Situational 15 (2)
Vasodilatative carotid sinus syndrome 27 (3)
Cardio-inhibitory carotid sinus syndrome 96 (10)
Psychogenic pseudosyncope 129 (14)
Orthostatic hypotension 31 (3)
Cardiac arrhythmias 52 (6)
Tachyarrhythmias 35 (4)
Supraventricular tachycardia 19 (2)
Ventricular tachycardia 16 (2)
Bradyarrhythmias 17 (2)
Sick sinus syndrome 9 (1)
AV block 8 (1)
Miscellaneous 12 (1)
Unexplained 319 (34)
27%. Cardioinhibitory CSS was diagnosed in 96
patients (10%) and psychogenic pseudo-syncope
in 131 (14%), with spontaneous hysterical con-
version or panic attacks in 22% and triggered by
HYV in 78% of these 131 patients. The distribu-
tion of final diagnoses according to age <70 years
(n = 241) versus ≥70 years (n = 78) and men (n =
168) versus women (n = 151) was analyzed. Syn-
cope remained unexplained in 1/3 of all cases,
independent of age (34% vs 33%, respectively)
and gender (35% vs 33%, respectively). In pa-
tients<70 years of age, vasovagal and psychogenic
causes combined were significantly more preva-
lent (49%) and arrhythmic and hypotensive causes
less prevalent (10% and 4%, respectively) than in
patients ≥70 years of age (17%, 34%, and 13%,
respectively, P < 0.01).
Diagnostic Yield of Individual Tests
Table III shows the diagnostic yield of individ-
ual tests. Since the standardized evaluation was
applied sequentially, not all tests were systemat-
ically performed. Among noninvasive tests, HYV
yielded the best diagnostic performance (49%) fol-
lowed by HUTT (38%), CSM (28%), and long-
term ECG recordings (28%). HYV and long-term
ECG recordings were used selectively, in patients
with psychiatric manifestations and ≥1 episode
of syncope/week. Among invasive tests, the di-
agnostic performance of EPS was poor (22%) de-
spite a strict patient selection. In contrast, ILR
yielded a diagnosis in 30 of 54 patients (56%),
who presented with syncope-related complica-
tions and a negative noninvasive diagnostic eval-
uation. An arrhythmic cause was confirmed in
20% of patients, including sick sinus syndrome
in 11%, and supraventricular tachyarrhythmias
in 9%. A hypotensive cause was suspected in
17% on the basis of the ILR recorded heart rate
Table III.
Diagnostic Yield of Individual Tests
Electrocardiogram 10/939 (1)
Orthostatic blood pressure test 37/870 (4)
Head-up tilt test 317/844 (38)
Carotid sinus massage 200/714 (28)
Hyperventilation test 140/284 (49)
Long-term electrocardiogram 16/58 (28)
Echocardiogram 10/143 (7)
Exercise test 8/70 (12)
Electrophysiological study 35/156 (22)
Implantable loop-recorder 30/54 (56)
Values are numbers of diagnostic tests/number of tests
performed (% yield).
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Table IV.
Baseline Clinical Characteristics and Distribution of Statistically* Significant Prodromes According to Causes of Syncope
Arrhythmia VV/Psy Hypotension Miscellaneous Unexplained Total
n = 148 n = 387 n = 58 n = 27 n = 319 n = 939
Age (year) 67 ± 11 43 ± 16 64 ± 15 55 ± 14 53 ± 21 52 ± 21
Women 58 (39) 224 (58) 20 (34) 8 (30) 151 (47) 461 (49)
Hypertension 65 (44) 56 (15) 26 (44) 9 (33) 105 (33) 261 (28)
Ischemic heart disease 29 (20) 13 (3) 10 (17) 1 (4) 24 (8) 77 (8)
NYHA class ≥ II 44 (30) 14 (4) 19 (32) 6 (22) 31 (10) 114 (12)
P-wave duration (ms) 112 ± 16 98 ± 12 113 ± 16 108 ± 12 103 ± 16 103 ± 15
QRS duration (ms) 97 ± 15 88 ± 11 95 ± 16 92 ± 11 92 ± 15 91 ± 14
No prodrome 69 (47) 25 (6) 15 (25) 5 (19) 135 (42) 249 (27)
Nausea/vomiting 19 (13) 129 (33) 6 (10) 3 (11) 36 (11) 193 (21)
Diaphoresis 42 (28) 316 (82) 19 (33) 11 (41) 104 (33) 492 (52)
Blurred vision 26 (18) 191 (49) 27 (46) 8 (30) 82 (25) 334 (36)
Paresthesia 2 (1) 85 (22) 2 (3) 1 (4) 15 (5) 105 (11)
Vertigo/dizziness 54 (36) 235 (61) 28 (47) 17 (63) 92 (29) 426 (45)
Palpitations 9 (6) 82 (21) 4 (7) 4 (15) 29 (9) 128 (14)
Mean ± standard deviation, unmarked data are n (%).
*P < 0.01 in the comparison of Rhythm, VV/Psy and other three categories pooled.
VV/Psy = pooled vasovagal syncope and psychogenic pseudo-syncope; NYHA = New York Heart Association.
during clinical events and confirmed by selected
tests. The remaining causes of syncope included
vasovagal (9%), epilepsy (6%), situational (2%),
and psychogenic (2%). It is noteworthy that the
three patients diagnosed with epilepsy had a
negative neurological evaluation, including elec-
troencephalogram before ILR implantation. Impor-
tantly, 92% of the final causes of syncope were
identified using noninvasive tests, while invasive
test yielded diagnoses in an additional 8% of
patients.
Clinical Characteristics and Distribution of
Prodromes According to the Final Diagnosis
Table IV shows the baseline clinical charac-
teristics and distribution of statistically significant
prodromes according to causes of syncope. Com-
pared with vasovagal syncope and psychogenic
pseudo-syncope, patients with arrhythmic causes
were older, had a lower functional capacity, a
higher prevalence of hypertension and ischemic
heart disease, a longer P-wave but similar QRS
duration, and suffered more often from sudden
syncope. Prodromes, such as nausea, diaphoresis,
paresthesia, palpitations, and anxiety, were sig-
nificantly more common in patients with vaso-
vagal syncope and psychogenic pseudo-syncope
than in patients with arrhythmic causes or other
categories.
Discussion
Distribution of Causes of Syncope
The application of a standardized stepwise
diagnostic evaluation identified a cause of syn-
cope in 66% of patients. The distribution of final
diagnoses is concordant with previous reports.6
Vasovagal (HUTT-induced) syncope was the most
prevalent cause, while cardiac arrhythmias were
uncommon. The higher prevalence of vasovagal
syncope in younger and arrhythmic causes in
older patients is concordant with previous stud-
ies.4,7,8 On the other hand, the 14% prevalence
of psychogenic pseudo-syncope in our study is
at variance with other studies, which reported
<6% psychogenic origins of syncope.2,6 Others,
however, have underestimated its true prevalence,
which might be as high as 24% in a popu-
lation presenting with unexplained syncope.9,10
Patients with psychogenic pseudo-syncope were
rather young, women, and frequently suffered
from presyncope, suggesting that psychiatric man-
ifestations should be routinely sought in patients
with unexplained syncope, and that psychogenic
pseudo-syncope is not only a diagnosis of exclu-
sion but can be firmly established. Following the
standardized diagnostic evaluation, 1/3 of our pa-
tients remained without an explained cause. They
shared some common characteristicswith arrhyth-
mic causes, such as a high prevalence of abrupt
onset (43%) compared with other categories. In
PACE, Vol. 32 March 2009, Supplement 1 S205
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54 of these patients an IRL was implanted and,
surprisingly, multiple etiologies were finally es-
tablished.
Diagnostic Yield of a Standardized Stepwise
Evaluation
The diagnostic approach of patients with un-
explained syncope is a clinical challenge. De-
spite multiple investigations, syncope remains
unexplained in up to approximately 50% of
cases.1,2 The superiority of standardized investiga-
tion strategies of unexplained syncope over usual
practice has been recently shown in patients with
syncope admitted to emergency departments.1–3
The present study suggests that a standardized
stepwise diagnostic evaluation establishes an eti-
ology in 2/3 of patients referred for unexplained
syncope to an outpatient clinic, a proportion con-
cordant with other studies,2,4 and highlights the
use of noninvasive tests for the investigation of un-
explained recurrent syncope. In selected patients,
however, ILR established a diagnosis in over 50%
of recipients, confirming its incremental benefit in
patients with unexplained syncope after a nega-
tive standardized diagnostic evaluation.
Clinical Characteristics and Distribution of
Prodromes According to Causes of Syncope
Alboni et al. and Sheldon et al. recently ob-
served an older age and fewer prodromes in pa-
tients with carotid sinus hypersensitivity or car-
diac syncope compared with patients who present
with other forms of neurally mediated syncope.7,8
Our study extends these observations to other
causes of cardiac syncope. Patients with arrhyth-
mic events were older, had a higher prevalence of
hypertension and ischemic heart disease, and re-
ported fewer prodromes. Their functional capac-
ity was lower and P-wave duration longer than in
patients with reflex syncope. This study of >900
patients confirms our previous observations4 that
clinical characteristics, syncope presentation, and
P-wave duration may be used to identify a sub-
group of patients more likely to suffer from ar-
rhythmic syncope.
Limitations of the Study
The first limitation of our study was the
absence of objective criteria for the diagnosis of
psychogenic pseudo-syncope, which may have
overestimated the true prevalence of this disor-
der. Final diagnoses, however, were established
when the test-induced symptoms strictly matched
the clinical event. Second, Krahn et al. recently re-
ported a higher cost-effectiveness of the ILR over
conventional testing in a similar design.11 The di-
agnostic yield of conventional testing was surpris-
ingly low (20%) compared with the present study
(66%). The effectiveness of our stepwise evalu-
ation needs to be addressed and compared with
other investigation strategies in terms of recur-
rence and cost.
Conclusions
A standardized stepwise diagnostic evalu-
ation focusing on noninvasive tests identified
two-thirds of causes in patients referred to an
ambulatory clinic for unexplained syncope. Vaso-
vagal syncope and psychogenic pseudo-syncope
accounted for >50% of all causes, while cardiac
arrhythmias were uncommon. Sudden syncope,
especially in older patients with functional limi-
tations or a prolonged P-wave duration, suggested
an arrhythmic cause.
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